PhaseBio Pharmaceuticals, Inc. (PHAS)

Accounts Payable

$6.32M

Quarterly · Period ending: · USD

PHAS logo

PHAS Accounts Payable

Latest reported$6.32M
PHAS Quarterly Accounts Payable ($430.00K → $6.32M)
High-resolution chart · PNG

PHAS accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
6,320,000
6,778,000
12,570,000
8,521,000
2,958,000
5,898,000
3,674,000
2,124,000
6,967,000
1,918,000
2,921,000
1,659,000
3,047,000
2,058,000
1,806,000
1,576,000
569,000
430,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.